A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases - Yi Zang; Jingjing Shi; Guanguan Zhao; Bixi Tang; Mingliang Liu; Benqiang Yao; Gaihong Wang; Hualing Pan; Shengsheng Yang; Rong Deng; Yishuang Zhao; Zhenwei Zhang; et al. (Nature, 2026)